Modarresi A, Shovlin CL. Integration of genotypic data into clinical trial design and reporting in hereditary hemorrhagic telangiectasia could help personalize treatment. haematol [Internet]. 2024Nov.1 [cited 2024Nov.5];109(11):3826-7. Available from: https://haematologica.org/article/view/haematol.2024.285809